Switch Maintenance Study
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2612965
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: CapeOX+Bev ;Capecitabine1000mg/m2 oral administration twice a day Day1-15+Oxaliplatin130mg/m2 120minute DIV+Bevacizumab5.0 mg/kg given on day 1,15
FOLFOX+Bev;Oxaliplatin85mg/m2 120minute DIV+LEVOFOLINATE200mg/m2 120minute DIV+Fluorouracil400mg/m2 rapid DIV+Fluorouracil2400mg/m2 46minute DIV+Bevacizumab DIV5.0 mg/kg Day1,15
TAS-102+Bev;TAS-102 35 mg/m2/time,oral administration twice a day Day1-5,
TAS-102 oral administration twice a day Day8-12+Bevacizumab DIV5.0 mg/kg Day1,15
Primary outcome(s): Progression free survival
Study Design: single arm study, open(masking not used), uncontrolled control, single assignment, treatment purpose
创建时间：
2018-01-15
